Dear ASPS Community Friends,
I am becoming increasingly concerned about the use of whole brain radiation treatment (WBRT) for ASPS brain mets based on several anecdotal ASPS patient failed treatment experiences and results with this seemingly ineffective treatment which is at best only palliative and not curative. I think that it is very important that ASPS patients be well informed, that they explore all other possible treatment options, and that they proceed very cautiously before undergoing WBRT. Based on my close observations of the past several years, it appears that WBRT is not effective in preventing the development and increased growth of ASPS brain mets probably because ASPS is so notoriously radiation resistant, and since it is not possible to administer a large enough dosage of radiation to the entire brain with WBR, as opposed to the intensive targeted radiation which can be administered with Gamma Knife or Cyberknife treatment for individual small brain mets. A validated and very serious possible side effect of WBRT is permanent debilitating short term memory loss and mental confusion which I personally know was tragically experienced by at least two ASPS patients treated with WBRT. Based on these anecdotal observations of failed efficacy of the treatment and the known potential for severe memory impairment and functioning, I personally feel that WBRT should be used only if there are no other viable treatment options, and if potential benefits of the treatment can be documented with available data to ourweigh the considerable risks. Based on our personal experience with Brittany's multiple brain mets during the past five years, resection, if the tumor can be safely surgically removed, seems to be the best treatment option. If the tumor cannot be successfully resected because of location, and if the tumor is small enough to successfully respond to radiosurgery (less than four millimeters in our experience) Gamma Knife or Cyberknife seem to be the next best option to try to kill/shrink the tumor. An effective systemic treatment to try to prevent the development of new brain mets seems to be a better option than WBRT, but the treatment must be able to cross the blood brain barriar. However,if the location, size, and the number of tumors make it impossible to surgically remove or to Gamma Knife or Cyberknife the tumor/tumors, and if no effective systemic treatment is available, then WBRT may have to be considered as a treatment option. I am not a doctor, and I do not intend to provide medical advice, but I just want to share my anecdotal observations and concerns regarding this treatment which too many doctors seem to continue to advocate and prescribe despite the dismal record of treatment success and outcome for patients with ASPS brain mets. I welcome any further input or opinions from anyone who may have any personal experiences or anecdotal or researched information to share with this Forum regarding this treatment.
With special caring thoughts and continued Hope,
Bonni
CureASPS Member
Posts: 151
Joined: Tue Aug 15, 2006 6:32 am
Location: Sammamish, WA USA
Private message
Concerns about whole brain radiation treatment for ASPS
Treatment of brain metastases.
-
- Senior Member
- Posts: 1678
- Joined: Mon Aug 14, 2006 11:32 pm
- Location: Sammamish, WA USA
Jump to
- Welcome to CureASPS.org!
- ↳ Guest Book
- ↳ Forum Issues and Suggestions
- News and Updates
- ↳ Personal Stories and Updates
- ↳ Success Stories
- ↳ Rest In Peace
- ↳ Anonymous Patient Updates
- ↳ Chinese group news
- ↳ Medical Publications
- ↳ Other Publications
- ↳ Sarcoma Meetings and Conferences
- ASPS Clinical Trials
- ↳ Other Clinical Trials
- ↳ COMPLETED - ARQ 197 Clinical Trial
- ↳ COMPLETED - Dana Farber Vaccine Clinical Trial (GVAX)
- ↳ Dasatinib
- ↳ Alisertib
- ↳ Cediranib
- ↳ Anlotinib
- ↳ Immune checkpoint inhibitors (ICI)
- ↳ Axitinib and Pembrolizumab (Keytruda) in Miami, US
- ↳ TECENTRIQ (atezolizumab) by Genentech
- ↳ Pfizer's PF-06801591
- ↳ Durvalumab+Tremelimumab at MDACC
- Symptoms and Diagnostics
- ↳ Symptoms
- ↳ Scan Types and Follow-Up
- ↳ Molecular Studies
- ↳ Pathology results
- Primary Tumor Treatment
- ↳ Resection
- ↳ Treatment of Non-Resectable Primary Tumor
- ↳ Radiation
- Systemic Treatment
- ↳ TKI
- ↳ Sutent (sunitinib)
- ↳ Pazopanib
- ↳ Сabozantinib (Cometriq)
- ↳ Sorafenib
- ↳ Chemotherapy
- ↳ Metronomic chemotherapy
- ↳ Temozolomide (Temodar)
- ↳ Side effects of systemic treatments
- ↳ Interferon alpha
- ↳ Immune checkpoint inhibitors ICI (PD-1 and PD-L1 targeting drugs)
- ↳ Keytruda
- ↳ Opdivo
- ↳ TECENTRIQ (atezolizumab)
- ↳ Toxicity, problems and potentiation strategies
- ↳ Treatment response criteria and evaluation/scanning problems/rare cases
- ↳ treatment discontinuation/re-treatment
- Metastatic Disease Treatment
- ↳ Local treatment modalities
- ↳ cryoablation
- ↳ Side effects/complications of the local ablations
- ↳ Radiosurgery
- ↳ Microwave ablation
- ↳ High intensity focused ultrasound (HIFU)
- ↳ Lung Metastases
- ↳ Laser assisted surgery
- ↳ Brain Metastases
- ↳ Bone Metastases
- ↳ Other Metastases
- ↳ Abdominal Metastases
- ↳ Liver metastases
- ↳ Heart Metastases
- ↳ Spinal metastases
- ↳ Adrenal metastases
- ↳ Pancreatic metastases
- Living with ASPS
- ↳ Insurance Coverage
- ↳ Second opinion from a sarcoma center
- ↳ Finanical assistance
- ↳ Diet and lifestyle
- ↳ Related studies
- ↳ Pain management
- ↳ Travel assistance